Email Alert | RSS    帮助

中国防痨杂志 ›› 2015, Vol. 37 ›› Issue (2): 128-133.doi: 10.3969/j.issn.1000-6621.2015.02.003

• 论著 • 上一篇    下一篇

肺结核患者血清视黄醇和视黄醇结合蛋白4水平变化的研究

麦洪珍 杨智 宋晓东 蔡春葵 路希维   

  1. 116033 大连市结核病医院结核内科
  • 收稿日期:2014-10-23 出版日期:2015-02-10 发布日期:2015-03-21
  • 通信作者: 宋晓东 E-mail:xiaodongdong63@gmail.com
  • 基金资助:

    大连市卫生局科研基金项目(20110729)

Study on levels of serum retinol and retinol-binding protein-4 in patients with pulmonary tuberculosis

MAI Hong-zhen, YANG Zhi, SONG Xiao-dong, CAI Chun-kui, LU Xi-wei   

  1. Department of Medicine, Dalian Tuberculosis Hospital, Dalian 116033, China
  • Received:2014-10-23 Online:2015-02-10 Published:2015-03-21
  • Contact: SONG Xiao-dong E-mail:xiaodongdong63@gmail.com

摘要: 目的 检测耐药肺结核、非耐药肺结核患者和健康对照者血清维生素A(视黄醇)和视黄醇结合蛋白4(retinol-binding protein-4,RBP4)水平,并分析它们的影响因素。方法 收集2011年7月至2013年8月大连市结核病医院门诊随访及住院治疗的耐药肺结核患者128例(耐药组)、非耐药肺结核患者152例 (非耐药组),匹配选取我院同期健康体检者120名作为对照组。采用高效液相色谱法(HPLC)测定上述受试者血清视黄醇水平,同时采用酶联免疫吸附测定法(ELISA)检测血清RBP4水平。结果以(x±s)表示,所有数据采用SPSS 15.0统计软件进行统计学分析。 多组间比较采用单因素方差分析及SNK-q检验,以P<0.05为差异有统计学意义。影响因素分析采用直线相关和多元逐步回归分析。 结果 耐药组、非耐药组患者血清视黄醇、RBP4水平分别为(206.10±10.35)μg/L、(6.22±1.64)μg/ml和(249.61±12.06)μg/L、(8.23±2.31)μg/ml,均显著低于对照组血清视黄醇、RBP4水平(326.57±11.52)μg/L、(11.52±2.60)μg/ml,差异均有统计学意义(q=12.35和 10.66,P值均<0.01;q=3.86和3.36, P值均<0.05);而耐药组较非耐药组,患者血清视黄醇、RBP4水平均显著降低,差异均有统计学意义(q=3.25和3.12, P值均<0.05)。多元逐步回归分析表明,体质量指数(BMI)是血清视黄醇和RBP4的独立影响因素(t=2.154和5.211,P值均<0.05)。 结论 肺结核患者血清视黄醇和RBP4水平均显著降低,耐药肺结核患者降低更明显。

关键词: 结核, 肺/血液, 维生素A, 视黄醇结合蛋白质类

Abstract: Objective To determine the levels of serum vitamin A (retinol) and retinol-binding protein-4 (RBP4) in drug-resistant pulmonary tuberculosis (PTB), susceptible PTB and healthy people; to analyze the related factors to influence the levels of serum retinol and RBP4.  Methods Outpatients and inpatients with PTB who received treatment in Dalian TB Hospital from July 2011 to August 2013 were recruited in this study, including 128 drug-resistant PTB patients (drug-resistant group) and 152 susceptible PTB patients (non drug-resistant group). Meanwhile, 120 matched healthy persons who received physical examinations in the same hospital were selected as the control group. The levels of serum retinol and serum RBP4 among all those recruited subjects were tested. The serum retinol was measured by high-performance liquid chromatography (HPLC) and the serum RBP4 was measured by enzyme-linked immunosorbent assay (ELISA). The results were showed as x±s and all data were analyzed using SPSS software version 15.0. ANOVA and SNK-q test were used for the comparisons among multi groups. P<0.05 was regarded as statistical significance. Linear correlation and multiple stepwise regression analysis were used for correlated factors analysis of the levels serum retinol and RBP4.  Results The levels of serum retinol and RBP4 in drug-resistant group and non drug-resistant group were (206.10±10.35) μg/L, (6.22±1.64) μg/ml and (249.61±12.06) μg/L, (8.23±2.31) μg/ml respectively, which were significantly lower than those in the control group ((326.57±11.52) μg/L and (11.52±2.60) μg/ml) (q=12.35, q=10.66, all P<0.01;q=3.86, q=3.36, all P<0.05); Furthermore, the levels of serum retinol and RBP4 in drug-resistant group were significantly lower than those in non drug-resistant group (q=3.25, q=3.12, all P<0.05). A multiple stepwise regression analysis showed that body mass index (BMI) was the only independent influencing factor of the levels of serum retinol and RBP4 (t=2.154, t=5.211, all P<0.05).  Conclusion The levels of serum retinol and RBP4 significantly decreased in PTB patients and the decrease was more obvious in drug-resistant PTB patients.

Key words: Tuberculosis, pulmonary/Blood, Vitamin A, Retinol-binding proteins